JPS60260520A - 医薬組成物 - Google Patents
医薬組成物Info
- Publication number
- JPS60260520A JPS60260520A JP59117957A JP11795784A JPS60260520A JP S60260520 A JPS60260520 A JP S60260520A JP 59117957 A JP59117957 A JP 59117957A JP 11795784 A JP11795784 A JP 11795784A JP S60260520 A JPS60260520 A JP S60260520A
- Authority
- JP
- Japan
- Prior art keywords
- active ingredient
- stalk
- drug composition
- group
- accumulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940079593 drug Drugs 0.000 title abstract description 12
- 239000003814 drug Substances 0.000 title abstract description 12
- 239000000203 mixture Substances 0.000 title abstract 3
- 239000004480 active ingredient Substances 0.000 claims abstract description 11
- 235000005769 Japanese ginseng Nutrition 0.000 claims description 11
- 241000168720 Panax japonicus Species 0.000 claims description 11
- 235000003174 Panax japonicus Nutrition 0.000 claims description 11
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 239000002775 capsule Substances 0.000 abstract description 7
- 241000196324 Embryophyta Species 0.000 abstract description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 abstract description 6
- 238000009825 accumulation Methods 0.000 abstract description 6
- 210000004185 liver Anatomy 0.000 abstract description 6
- 230000002503 metabolic effect Effects 0.000 abstract description 5
- BGEBZHIAGXMEMV-UHFFFAOYSA-N 5-methoxypsoralen Chemical compound O1C(=O)C=CC2=C1C=C1OC=CC1=C2OC BGEBZHIAGXMEMV-UHFFFAOYSA-N 0.000 abstract description 4
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 abstract description 4
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 abstract description 2
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 abstract description 2
- DBMJZOMNXBSRED-UHFFFAOYSA-N Bergamottin Natural products O1C(=O)C=CC2=C1C=C1OC=CC1=C2OCC=C(C)CCC=C(C)C DBMJZOMNXBSRED-UHFFFAOYSA-N 0.000 abstract description 2
- 229960002045 bergapten Drugs 0.000 abstract description 2
- KGZDKFWCIPZMRK-UHFFFAOYSA-N bergapten Natural products COC1C2=C(Cc3ccoc13)C=CC(=O)O2 KGZDKFWCIPZMRK-UHFFFAOYSA-N 0.000 abstract description 2
- 150000003943 catecholamines Chemical class 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 abstract description 2
- 229960002748 norepinephrine Drugs 0.000 abstract description 2
- 239000003960 organic solvent Substances 0.000 abstract description 2
- 230000003405 preventing effect Effects 0.000 abstract description 2
- 241001063953 Angelica shikokiana Species 0.000 abstract 3
- 210000000056 organ Anatomy 0.000 abstract 2
- 239000003925 fat Substances 0.000 abstract 1
- 150000002978 peroxides Chemical class 0.000 abstract 1
- 239000006187 pill Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 13
- 241000700159 Rattus Species 0.000 description 11
- 239000002285 corn oil Substances 0.000 description 11
- 235000005687 corn oil Nutrition 0.000 description 11
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- 241000208340 Araliaceae Species 0.000 description 9
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 9
- 235000003140 Panax quinquefolius Nutrition 0.000 description 9
- 235000008434 ginseng Nutrition 0.000 description 9
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- -1 lipid peroxide Chemical class 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 241000208173 Apiaceae Species 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 108010023302 HDL Cholesterol Proteins 0.000 description 2
- 206010067125 Liver injury Diseases 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 210000000748 cardiovascular system Anatomy 0.000 description 2
- 235000013345 egg yolk Nutrition 0.000 description 2
- 210000002969 egg yolk Anatomy 0.000 description 2
- 231100000234 hepatic damage Toxicity 0.000 description 2
- 230000008818 liver damage Effects 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 240000002234 Allium sativum Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical class OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000277269 Oncorhynchus masou Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000001913 cellulose Chemical class 0.000 description 1
- 229920002678 cellulose Chemical class 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 229940029982 garlic powder Drugs 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59117957A JPS60260520A (ja) | 1984-06-07 | 1984-06-07 | 医薬組成物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59117957A JPS60260520A (ja) | 1984-06-07 | 1984-06-07 | 医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS60260520A true JPS60260520A (ja) | 1985-12-23 |
| JPH043365B2 JPH043365B2 (enExample) | 1992-01-23 |
Family
ID=14724425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59117957A Granted JPS60260520A (ja) | 1984-06-07 | 1984-06-07 | 医薬組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS60260520A (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006082743A1 (ja) * | 2005-02-04 | 2006-08-10 | Takara Bio Inc. | 治療剤 |
| JP2016172711A (ja) * | 2015-03-16 | 2016-09-29 | 国立大学法人九州大学 | 血液凝固阻害剤及び血液凝固阻害剤の生産方法 |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000027224A1 (en) * | 1998-11-11 | 2000-05-18 | Manabu Nomura | Health-promoting foods |
| JP5988058B2 (ja) * | 2013-05-09 | 2016-09-07 | 国立大学法人九州大学 | 生産方法及び神経保護剤 |
-
1984
- 1984-06-07 JP JP59117957A patent/JPS60260520A/ja active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006082743A1 (ja) * | 2005-02-04 | 2006-08-10 | Takara Bio Inc. | 治療剤 |
| JP2016172711A (ja) * | 2015-03-16 | 2016-09-29 | 国立大学法人九州大学 | 血液凝固阻害剤及び血液凝固阻害剤の生産方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH043365B2 (enExample) | 1992-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3768795B2 (ja) | キサンチンオキシダーゼ阻害剤 | |
| US6329000B1 (en) | Extract of pine needle and the use thereof | |
| GB2503628A (en) | Pharmaceutical compostion for controlling blood sugar, blood lipid and body weight | |
| CN106822599A (zh) | 一种环草石斛提取物及其抗糖尿病用途 | |
| CN116919931A (zh) | 烟草提取物在制备预防和/或治疗糖尿病药物中的应用 | |
| CN102319289B (zh) | 肉桂多酚等组成的降血糖中药组合物及其制备方法 | |
| JP2014208620A (ja) | 抗肥満剤 | |
| CN100467031C (zh) | 牛蒡子总木脂素的医药用途 | |
| JP4371431B2 (ja) | 抗アレルギー性組成物 | |
| JPS60260520A (ja) | 医薬組成物 | |
| KR20070026329A (ko) | 우울증 치료를 위한 선인장 식물체 일부 및／또는 그추출물의 용도 | |
| KR102234860B1 (ko) | 싸리 추출물을 포함하는 근위축 예방 및 치료용 조성물 | |
| JP4601069B2 (ja) | 高脂血症治療のための相乗効果的医薬組成物 | |
| CN101274011A (zh) | 核桃壳提取物的制备及其在强心和心脑血管领域药物制剂的应用 | |
| JP7738743B2 (ja) | ピクロシドを含む医薬組成物 | |
| JP2001261569A (ja) | 抗肥満症剤 | |
| JP4610730B2 (ja) | カルシウム補給用の組成物 | |
| CN106572975B (zh) | 基于anthostema senegalense制备的组合物在制备治疗艾滋病的药物中的用途 | |
| CN105963330A (zh) | 神秘果制剂及其应用 | |
| CN112089783A (zh) | 中药组合物在制备预防或/和治疗肥胖的药物中的应用 | |
| RU2321419C1 (ru) | ЭКСТРАКТ Cetraria islandica (L.) Ach. СУХОЙ, ТАБЛЕТИРОВАННАЯ ФОРМА | |
| CN103432541A (zh) | 一种蘘荷花苞提取物的降血脂新用途 | |
| CN109432082A (zh) | 一种防治化学性肝损伤的药物组合物 | |
| JP3183758B2 (ja) | 血中中性脂肪改善剤及びその製造方法並びにこれを含有する組成物 | |
| CN103623258B (zh) | 一种治疗心绞痛的药物组合物及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |